Tenofovir disoproxil fumarate CAS NO.202138-50-9

Tenofovir fumarate is a nucleotide antiviral drug developed and marketed by Gilead company in the United States. It was approved by FDA in 2001 for the treatment of human immunodeficiency virus infection. It was listed in the European Union in 2002 and approved for the treatment of HIV-1 and chronic hepatitis B.

Tenofovir fumarate, as a nucleotide reverse transcriptase inhibitor, is an oral cyclic open nucleotide phosphate prodrug, which is rapidly converted into tenofovir after oral absorption.

Due to its high bioavailability, definite efficacy and good tolerance, TDF has become the recommended first-line anti HIV drug with the highest sales.

Nucleotide reverse transcriptase inhibitor, a prodrug of tenofovir (PMPA, 2), is mainly used in the treatment of human immunodeficiency virus infection

COMPANY INTRODUCTION

JIN DUN CHEMICAL belongs to JIN DUN GROUP. It is a professional enterprise dedicated to the development and production of special (meth)acrylate monomers. The head office is located in Shanghai city, near Hongqiao airport.The R&D center of JIN DUN is located in Ningbo city, Zhejiang province.  

JIN DUN CHEMICAL focus on the coating, automobile, electricity and pharmaceutical area, always try best to be the professional supplier of new raw material for the advanced material in coating, automobile chemicals, electricity chemicals and pharmaceutical intermediate.

The EU company of JIN DUN CHEMICAL located at Frankfurt in Germany. It makes us service our customer better in EU, but also takes more valued information for our creation and future developing.

Welcome our customers and friends to visit our company.